LOS ANGELES, July 20, 2017 -- Lundin Law PC, a shareholder rights firm, announces a class action lawsuit against Eco Science Solutions, Inc. (“Eco Science” or the “Company”) (Other OTC:ESSI) for possible violations of federal securities laws from December 2, 2016 through May 19, 2017 inclusive (the “Class Period”). Investors who purchased or otherwise acquired Eco Science shares during the Class Period should contact the firm prior to the July 24, 2017 lead plaintiff motion deadline.
To participate in this class action lawsuit, click here.
You can also call Brian Lundin, Esq., of Lundin Law PC, at 888-713-1033, or you can e-mail him at [email protected].
No class has been certified in the above action yet. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.
The Complaint states that throughout the Class Period, Eco Science made materially false and/or misleading statements, and/or failed to disclose, that its plan for strategic acquisitions lacked veracity. On May 19, 2017, the U.S. Securities and Exchange Commission (“SEC”) announced a temporary suspension of trading Eco Science securities “because of concerns regarding the accuracy and adequacy of publicly disseminated information concerning, among other things, ESSI’s proposed acquisition of Ga-Du Bank, Inc.”
Lundin Law PC was established by Brian Lundin, Esq., a securities litigator based in Los Angeles devoted to upholding shareholders’ rights.
This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contact: Lundin Law PC Brian Lundin, Esq. Telephone: 888-713-1033 Facsimile: 888-713-1125 [email protected] http://lundinlawpc.com/


FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
BP Nears $10 Billion Castrol Stake Sale to Stonepeak
Italy Fines Apple €98.6 Million Over App Store Dominance
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 



